Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT01774851
Status:
TERMINATED
Last Update Posted:
2017-06-22
First Post:
2013-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Sponsor:
Merrimack Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
None
Primary Completion Date:
2015-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-10
First Submit QC Date:
None
Study First Post Date:
2013-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-05-10
Results First Submit QC Date:
None
Results First Post Date:
2017-06-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-19
Last Update Post Date:
2017-06-22
Last Update Post Date Type:
ACTUAL